Dermatol. praxi. 2015;9(3):137-140

Pharmaceutical care of the scalp disease such as dandruff, seborrheic dermatitis and psoriasis

Mgr.Jana Martinásková
Lékárna Modrá hvězda, Bílovec

with localization on the scalp

This article reviews the OTC products and recommendations for the proper care of the scalp disease such as dandruff, seborrheic dermatitis

and psoriasis with localization on the scalp. Each of these diseases in varying degrees affects the quality of life of patients. To minimize bothersome

symptoms and reduce the frequency of relapses is preventive care by using the OTC dermocosmetics available in pharmacies important.

Keywords: dandruff, seborrheic dermatitis, psoriasis, scalp

Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Martinásková J. Pharmaceutical care of the scalp disease such as dandruff, seborrheic dermatitis and psoriasis. Dermatol. praxi. 2015;9(3):137-140.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Braun-Falco, O. Dermatology. Springer Science. Berlin, 2000: 465, ISBN: 3-540-59452-3.
    2. Schwartz JR. Textbook of Cosmetic Dermatology. CRC Press. 2010: 230-241, ISBN: 18484764X. Go to original source...
    3. Bergbrant IM, Faergemann J. The role of Pityrosporum ovale in seborrheic dermatitis. Seminars in Dermatology, 1990; 9(4): 262-268, PMID: 2149500. Go to PubMed...
    4. Guillot J, Guého E, Lesourd M, et al. Identification of Malassezia Species; J.Mycol Med 1996; 6: 103-110. ISSN: 1156-5233.
    5. Štork J, et al. Dermatovenerologie. Galén. Praha. 2013: 185-191, ISBN: 978-80-7262-898-8.
    6. Pierard-Franchimont C, Goffin V, Decrois J, Pierard G. A Multicenter Randomized Trial of Ketoconazole 2% and Zinc Pyrithione 1% Shanpoos in Severe Dandruff and Seborheic Dermatitis. Skin Pharmacology and Applied Skin Physiology 2002; 15(6): 434-441. ISSN: 1422-2906. Go to original source... Go to PubMed...
    7. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2,5% shampoo in the treatment of moderate to severe dandruff. Journal of the American Academy of Dermatology 1993; 29(6): 1008-1012. Go to original source... Go to PubMed...
    8. https://pubchem.ncbi.nlm.nih.gov/sompound/24087#section=Therapeutic-Uses, s odkazem na: American Society of Health System Pharmacists; AHFS, Drug Information, 2010: 3554.
    9. Sanfilippo A, English JC. An Owerwiew of Medicated Schampoos used in Dandruff threatment. P & T Review Article 2006; 31(7): 396-400.
    10. Remedia compendium. 2009. Panax. Praha. Čtvrté vydání. s. 776. ISBN: 978-80-902806-4-9.
    11. Čapková Š. Nejčastější kožní choroby v dětském věku a jejich léčba. Dermatologie pro praxi. 2009; 3(3): 119-124.
    12. www.sukl.cz, SPC Nizoral šampon.
    13. www.sukl.cz, SPC Micetal gel.
    14. Noguera J, Leris E, Alguero M, Boncomplete E. Grupo de trabajo Flutrimazol gel, Servicio Dermatologia, Instituto Dexeus. Barcelona. Revista Iberoamericana de Micologia. 1998; 15(1): 28-32. Journal Article, English Abstrakt.
    15. Remedia compendium. Panax. Praha. Čtvrté vydání. 2009: 789. ISBN: 978-80-902806-4-9.
    16. www.mediket.ch/cz/octopirox.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.